{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:22:58Z","timestamp":1789521778097,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T00:00:00Z","timestamp":1674172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T00:00:00Z","timestamp":1674172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s10557-023-07426-3","type":"journal-article","created":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T19:59:14Z","timestamp":1674244754000},"page":"555-568","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Bicyclol Alleviates Streptozotocin-induced Diabetic Cardiomyopathy By Inhibiting Chronic Inflammation\u00a0And Oxidative Stress"],"prefix":"10.1007","volume":"38","author":[{"given":"Lingxi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenghong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leiming","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minxiu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuedan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongsheng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9048-0092","authenticated-orcid":false,"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,20]]},"reference":[{"key":"7426_CR1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","volume":"138","author":"NH Cho","year":"2018","unstructured":"Cho NH, Shaw JE, Karuranga S, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271\u201381.","journal-title":"Diabetes Res Clin Pract"},{"issue":"10","key":"7426_CR2","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.2337\/dc14-1720","volume":"37","author":"SD de Ferranti","year":"2014","unstructured":"de Ferranti SD, de Boer IH, Fonseca V, et al. Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association. Diabetes Care. 2014;37(10):2843\u201363.","journal-title":"Diabetes Care"},{"issue":"3","key":"7426_CR3","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nrendo.2015.216","volume":"12","author":"G Jia","year":"2016","unstructured":"Jia G, DeMarco VG, Sowers JR. Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy. Nat Rev Endocrinol. 2016;12(3):144\u201353.","journal-title":"Nat Rev Endocrinol"},{"issue":"11","key":"7426_CR4","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.120.315913","volume":"126","author":"RH Ritchie","year":"2020","unstructured":"Ritchie RH, Abel ED. Basic Mechanisms of Diabetic Heart Disease. Circ Res. 2020;126(11):1501\u201325.","journal-title":"Circ Res"},{"issue":"3","key":"7426_CR5","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jacc.2017.11.019","volume":"71","author":"TH Marwick","year":"2018","unstructured":"Marwick TH, Ritchie R, Shaw JE, Kaye D. Implications of underlying mechanisms for the recognition and management of diabetic cardiomyopathy. J Am Coll Cardiol. 2018;71(3):339\u201351.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"7426_CR6","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1016\/j.ijcard.2013.07.150","volume":"168","author":"X Palomer","year":"2013","unstructured":"Palomer X, Salvad\u00f3 L, Barroso E, V\u00e1zquez-Carrera M. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy. Int J Cardiol. 2013;168(4):3160\u201372.","journal-title":"Int J Cardiol"},{"issue":"4","key":"7426_CR7","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1007\/s00125-014-3171-6","volume":"57","author":"H Bugger","year":"2014","unstructured":"Bugger H, Abel ED. Molecular mechanisms of diabetic cardiomyopathy. Diabetologia. 2014;57(4):660\u201371.","journal-title":"Diabetologia."},{"key":"7426_CR8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.freeradbiomed.2021.02.043","volume":"167","author":"D Bou-Teen","year":"2021","unstructured":"Bou-Teen D, Kaludercic N, Weissman D, et al. Mitochondrial ROS and mitochondria-targeted antioxidants in the aged heart. Free Radic Biol Med. 2021;167:109\u201324.","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"7426_CR9","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.imbio.2018.11.010","volume":"224","author":"E Rendra","year":"2019","unstructured":"Rendra E, Riabov V, Mossel DM, et al. Reactive oxygen species (ROS) in macrophage activation and function in diabetes. Immunobiology. 2019;224(2):242\u201353.","journal-title":"Immunobiology."},{"issue":"5","key":"7426_CR10","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.jpba.2010.11.034","volume":"54","author":"YH Wang","year":"2011","unstructured":"Wang YH, Qiu C, Wang DW, et al. Identification of multiple constituents in the traditional Chinese medicine formula Sheng-Mai San and rat plasma after oral administration by HPLC-DAD-MS\/MS. J Pharm Biomed Anal. 2011;54(5):1110\u201327.","journal-title":"J Pharm Biomed Anal"},{"issue":"5","key":"7426_CR11","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1159\/000494791","volume":"50","author":"J Tian","year":"2018","unstructured":"Tian J, Tang W, Xu M, et al. Shengmai San alleviates diabetic Ccardiomyopathy through improvement of mitochondrial lipid metabolic disorder. Cell Physiol Biochem. 2018;50(5):1726\u201339.","journal-title":"Cell Physiol Biochem"},{"key":"7426_CR12","doi-asserted-by":"publisher","first-page":"107308","DOI":"10.1016\/j.intimp.2020.107308","volume":"91","author":"T Zhao","year":"2021","unstructured":"Zhao T, Mao L, Yu Z, et al. Therapeutic potential of bicyclol in liver diseases: lessons from a synthetic drug based on herbal derivative in traditional Chinese medicine. Int Immunopharmacol. 2021;91:107308.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"7426_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1139\/cjpp-2015-0074","volume":"94","author":"XM Yao","year":"2016","unstructured":"Yao XM, Li Y, Li HW, et al. Bicyclol attenuates tetracycline-induced fatty liver associated with inhibition of hepatic ER stress and apoptosis in mice. Can J Physiol Pharmacol. 2016;94(1):1\u20138.","journal-title":"Can J Physiol Pharmacol"},{"issue":"6","key":"7426_CR14","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1631\/jzus.B1200263","volume":"14","author":"J Cui","year":"2013","unstructured":"Cui J, Li Z, Qian LB, et al. Reducing the oxidative stress mediates the cardioprotection of bicyclol against ischemia-reperfusion injury in rats. J Zhejiang Univ Sci B. 2013;14(6):487\u201395.","journal-title":"J Zhejiang Univ Sci B"},{"key":"7426_CR15","doi-asserted-by":"publisher","first-page":"111874","DOI":"10.1016\/j.biopha.2021.111874","volume":"141","author":"W Zhao","year":"2021","unstructured":"Zhao W, Yan Y, Xiao Z, et al. Bicyclol ameliorates nonalcoholic fatty liver disease in mice via inhibiting MAPKs and NF-kappaB signaling pathways. Biomed Pharmacother. 2021;141:111874.","journal-title":"Biomed Pharmacother"},{"key":"7426_CR16","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.ejmech.2018.02.008","volume":"148","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Liu Z, Wu J, et al. New MD2 inhibitors derived from curcumin with improved anti-inflammatory activity. Eur J Med Chem. 2018;148:291\u2013305.","journal-title":"Eur J Med Chem"},{"key":"7426_CR17","doi-asserted-by":"crossref","unstructured":"Chen Y, Lin W, Zhong L, et al. Bicyclol attenuates obesity-induced cardiomyopathy via inhibiting NF-kappaB and MAPK signaling pathways. Cardiovasc Drugs Ther. 2022. online ahead of print.","DOI":"10.21203\/rs.3.rs-1537063\/v1"},{"issue":"3","key":"7426_CR18","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1111\/jcmm.13477","volume":"22","author":"S You","year":"2018","unstructured":"You S, Qian J, Sun C, et al. An Aza resveratrol-chalcone derivative 6b protects mice against diabetic cardiomyopathy by alleviating inflammation and oxidative stress. J Cell Mol Med. 2018;22(3):1931\u201343.","journal-title":"J Cell Mol Med"},{"key":"7426_CR19","doi-asserted-by":"publisher","first-page":"152774","DOI":"10.1016\/j.phymed.2018.11.034","volume":"59","author":"L Li","year":"2019","unstructured":"Li L, Luo W, Qian Y, et al. Luteolin protects against diabetic cardiomyopathy by inhibiting NF-kappaB-mediated inflammation and activating the Nrf2-mediated antioxidant responses. Phytomedicine. 2019;59:152774.","journal-title":"Phytomedicine."},{"key":"7426_CR20","doi-asserted-by":"publisher","first-page":"3959390","DOI":"10.1155\/2022\/3959390","volume":"2022","author":"Y Gao","year":"2022","unstructured":"Gao Y, Liu W, Su X, et al. The beneficial effects of Chinese herbal monomers on ameliorating diabetic cardiomyopathy via Nrf2 signaling. Oxidative Med Cell Longev. 2022;2022:3959390.","journal-title":"Oxidative Med Cell Longev"},{"key":"7426_CR21","doi-asserted-by":"publisher","first-page":"8214541","DOI":"10.1155\/2017\/8214541","volume":"2017","author":"J Tian","year":"2017","unstructured":"Tian J, Zhao Y, Liu Y, et al. Roles and mechanisms of herbal medicine for diabetic cardiomyopathy: current status and perspective. Oxidative Med Cell Longev. 2017;2017:8214541.","journal-title":"Oxidative Med Cell Longev"},{"issue":"3","key":"7426_CR22","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/jb\/mvab047","volume":"170","author":"X Liu","year":"2021","unstructured":"Liu X, Guo B, Zhang W, Ma B, Li Y. MiR-20a-5p overexpression prevented diabetic cardiomyopathy via inhibition of cardiomyocyte apoptosis, hypertrophy, fibrosis and JNK\/NF-kappaB signalling pathway. J Biochem. 2021;170(3):349\u201362.","journal-title":"J Biochem"},{"issue":"12","key":"7426_CR23","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1177\/1535370219861283","volume":"244","author":"Q Ge","year":"2019","unstructured":"Ge Q, Zhao L, Ren XM, Ye P, Hu ZY. LCZ696, an angiotensin receptor-neprilysin inhibitor, ameliorates diabetic cardiomyopathy by inhibiting inflammation, oxidative stress and apoptosis. Exp Biol Med (Maywood). 2019;244(12):1028\u201339.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"2","key":"7426_CR24","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s12012-015-9321-3","volume":"16","author":"Y Gao","year":"2016","unstructured":"Gao Y, Kang L, Li C, et al. Resveratrol ameliorates diabetes-induced cardiac dysfunction through AT1R-ERK\/p38 MAPK signaling pathway. Cardiovasc Toxicol. 2016;16(2):130\u20137.","journal-title":"Cardiovasc Toxicol"},{"issue":"2","key":"7426_CR25","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1002\/jcp.27070","volume":"234","author":"G Zuo","year":"2019","unstructured":"Zuo G, Ren X, Qian X, et al. Inhibition of JNK and p38 MAPK-mediated inflammation and apoptosis by ivabradine improves cardiac function in streptozotocin-induced diabetic cardiomyopathy. J Cell Physiol. 2019;234(2):1925\u201336.","journal-title":"J Cell Physiol"},{"issue":"1","key":"7426_CR26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00125-017-4390-4","volume":"61","author":"G Jia","year":"2018","unstructured":"Jia G, Whaley-Connell A, Sowers JR. Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease. Diabetologia. 2018;61(1):21\u20138.","journal-title":"Diabetologia."},{"issue":"Suppl 1","key":"7426_CR27","doi-asserted-by":"publisher","first-page":"60","DOI":"10.4158\/EP.12.S1.60","volume":"12","author":"A Ceriello","year":"2006","unstructured":"Ceriello A. Oxidative stress and diabetes-associated complications. Endocr Pract. 2006;12(Suppl 1):60\u20132.","journal-title":"Endocr Pract"},{"issue":"20","key":"7426_CR28","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1016\/j.jacc.2009.07.031","volume":"54","author":"EJ Anderson","year":"2009","unstructured":"Anderson EJ, Kypson AP, Rodriguez E, et al. Substrate-specific derangements in mitochondrial metabolism and redox balance in the atrium of the type 2 diabetic human heart. J Am Coll Cardiol. 2009;54(20):1891\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"7426_CR29","doi-asserted-by":"publisher","first-page":"5474","DOI":"10.3390\/molecules25225474","volume":"25","author":"S Saha","year":"2020","unstructured":"Saha S, Buttari B, Panieri E, Profumo E, Saso L. An overview of Nrf2 signaling pathway and its role in inflammation. Molecules. 2020;25(22):5474.","journal-title":"Molecules."},{"issue":"1","key":"7426_CR30","doi-asserted-by":"publisher","first-page":"678","DOI":"10.3892\/etm.2021.10110","volume":"22","author":"X Wu","year":"2021","unstructured":"Wu X, Huang L, Liu J. Relationship between oxidative stress and nuclear factor-erythroid-2-related factor 2 signaling in diabetic cardiomyopathy. Exp Ther Med. 2021;22(1):678.","journal-title":"Exp Ther Med"},{"issue":"1","key":"7426_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/cvr\/cvt204","volume":"100","author":"JL Balligand","year":"2013","unstructured":"Balligand JL. Reducing damage through Nrf-2. Cardiovasc Res. 2013;100(1):1\u20133.","journal-title":"Cardiovasc Res"},{"issue":"3","key":"7426_CR32","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1007\/s11033-021-06257-5","volume":"48","author":"A Gupta","year":"2021","unstructured":"Gupta A, Behl T, Sehgal A, et al. Therapeutic potential of Nrf-2 pathway in the treatment of diabetic neuropathy and nephropathy. Mol Biol Rep. 2021;48(3):2761\u201374.","journal-title":"Mol Biol Rep"},{"issue":"2","key":"7426_CR33","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1111\/jcmm.14870","volume":"24","author":"J Luo","year":"2020","unstructured":"Luo J, Yan D, Li S, et al. Allopurinol reduces oxidative stress and activates Nrf2\/p62 to attenuate diabetic cardiomyopathy in rats. J Cell Mol Med. 2020;24(2):1760\u201373.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"7426_CR34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1755-5922.2010.00218.x","volume":"30","author":"AA Elmarakby","year":"2012","unstructured":"Elmarakby AA, Sullivan JC. Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy. Cardiovasc Ther. 2012;30(1):49\u201359.","journal-title":"Cardiovasc Ther"},{"key":"7426_CR35","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.pharmthera.2016.03.005","volume":"161","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Ren J. Epigenetics and obesity cardiomyopathy: From pathophysiology to prevention and management. Pharmacol Ther. 2016;161:52\u201366.","journal-title":"Pharmacol Ther"},{"issue":"2","key":"7426_CR36","doi-asserted-by":"publisher","first-page":"e12418","DOI":"10.1111\/jpi.12418","volume":"63","author":"M Zhang","year":"2017","unstructured":"Zhang M, Lin J, Wang S, et al. Melatonin protects against diabetic cardiomyopathy through Mst1\/Sirt3 signaling. J Pineal Res. 2017;63(2):e12418.","journal-title":"J Pineal Res."},{"issue":"2","key":"7426_CR37","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/aps.2009.194","volume":"31","author":"XQ Bao","year":"2010","unstructured":"Bao XQ, Liu GT. Bicyclol protects HepG2 cells against D-galactosamine-induced apoptosis through inducing heat shock protein 27 and mitochondria associated pathway. Acta Pharmacol Sin. 2010;31(2):219\u201326.","journal-title":"Acta Pharmacol Sin"},{"issue":"6","key":"7426_CR38","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1080\/03639045.2022.2106238","volume":"48","author":"S Jia","year":"2022","unstructured":"Jia S, Jin L, Cheng X, et al. Bicyclol alleviates high-fat diet-induced hepatic ER stress- and autophagy-associated non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis in mice. Drug Dev Ind Pharm. 2022;48(6):247\u201354.","journal-title":"Drug Dev Ind Pharm"},{"issue":"2","key":"7426_CR39","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrendo.2017.151","volume":"14","author":"Y Zheng","year":"2018","unstructured":"Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88\u201398.","journal-title":"Nat Rev Endocrinol"},{"issue":"10","key":"7426_CR40","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1007\/s00125-012-2652-8","volume":"55","author":"DC Henstridge","year":"2012","unstructured":"Henstridge DC, Bruce CR, Pang CP, et al. Skeletal muscle-specific overproduction of constitutively activated c-Jun N-terminal kinase (JNK) induces insulin resistance in mice. Diabetologia. 2012;55(10):2769\u201378.","journal-title":"Diabetologia."},{"key":"7426_CR41","doi-asserted-by":"publisher","first-page":"644129","DOI":"10.3389\/fphar.2021.644129","volume":"12","author":"H Li","year":"2021","unstructured":"Li H, Xu Q, Xu C, et al. Bicyclol regulates hepatic gluconeogenesis in rats with type 2 diabetes and non-alcoholic fatty liver disease by inhibiting inflammation. Front Pharmacol. 2021;12:644129.","journal-title":"Front Pharmacol"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-023-07426-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-023-07426-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-023-07426-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T06:24:16Z","timestamp":1715927056000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-023-07426-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,20]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["7426"],"URL":"https:\/\/doi.org\/10.1007\/s10557-023-07426-3","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,20]]},"assertion":[{"value":"3 January 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were in compliance with the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved by the Welfare Committee of Wenzhou Medical University (Approved ID: wydw2018-0124).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Statement"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors declare that they have no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}